Engelhard VH - Search Results

1

Deletional self-tolerance to a melanocyte/melanoma antigen derived from tyrosinase is mediated by a radio-resistant cell in peripheral and mesenteric lymph nodes.

Nichols LA, Chen Y, Colella TA, Bennett CL, Clausen BE, Engelhard VH. Nichols LA, et al. Among authors: engelhard vh. J Immunol. 2007 Jul 15;179(2):993-1003. doi: 10.4049/jimmunol.179.2.993. J Immunol. 2007. PMID: 17617591

2

Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy.

Engelhard VH, Bullock TN, Colella TA, Sheasley SL, Mullins DW. Engelhard VH, et al. Immunol Rev. 2002 Oct;188:136-46. doi: 10.1034/j.1600-065x.2002.18812.x. Immunol Rev. 2002. PMID: 12445287 Review.

3

Immunity to melanoma antigens: from self-tolerance to immunotherapy.

Slingluff CL Jr, Chianese-Bullock KA, Bullock TN, Grosh WW, Mullins DW, Nichols L, Olson W, Petroni G, Smolkin M, Engelhard VH. Slingluff CL Jr, et al. Among authors: engelhard vh. Adv Immunol. 2006;90:243-95. doi: 10.1016/S0065-2776(06)90007-8. Adv Immunol. 2006. PMID: 16730266 Review.

4

Incomplete differentiation of antigen-specific CD8 T cells in tumor-draining lymph nodes.

Hargadon KM, Brinkman CC, Sheasley-O'neill SL, Nichols LA, Bullock TN, Engelhard VH. Hargadon KM, et al. Among authors: engelhard vh. J Immunol. 2006 Nov 1;177(9):6081-90. doi: 10.4049/jimmunol.177.9.6081. J Immunol. 2006. PMID: 17056534

5

Strategies and challenges in eliciting immunity to melanoma.

Ferguson AR, Nichols LA, Zarling AL, Thompson ED, Brinkman CC, Hargadon KM, Bullock TN, Engelhard VH. Ferguson AR, et al. Among authors: engelhard vh. Immunol Rev. 2008 Apr;222:28-42. doi: 10.1111/j.1600-065X.2008.00620.x. Immunol Rev. 2008. PMID: 18363993 Free PMC article.

6

Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice.

Gregg RK, Nichols L, Chen Y, Lu B, Engelhard VH. Gregg RK, et al. Among authors: engelhard vh. J Immunol. 2010 Feb 15;184(4):1909-17. doi: 10.4049/jimmunol.0902778. Epub 2010 Jan 18. J Immunol. 2010. PMID: 20083666 Free PMC article.

7

Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine development.

Kittlesen DJ, Thompson LW, Gulden PH, Skipper JC, Colella TA, Shabanowitz J, Hunt DF, Engelhard VH, Slingluff CL Jr. Kittlesen DJ, et al. Among authors: engelhard vh. J Immunol. 1998 Mar 1;160(5):2099-106. J Immunol. 1998. PMID: 9498746

8

The density of peptides displayed by dendritic cells affects immune responses to human tyrosinase and gp100 in HLA-A2 transgenic mice.

Bullock TN, Colella TA, Engelhard VH. Bullock TN, et al. Among authors: engelhard vh. J Immunol. 2000 Mar 1;164(5):2354-61. doi: 10.4049/jimmunol.164.5.2354. J Immunol. 2000. PMID: 10679070

9

Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy.

Colella TA, Bullock TN, Russell LB, Mullins DW, Overwijk WW, Luckey CJ, Pierce RA, Restifo NP, Engelhard VH. Colella TA, et al. Among authors: engelhard vh. J Exp Med. 2000 Apr 3;191(7):1221-32. doi: 10.1084/jem.191.7.1221. J Exp Med. 2000. PMID: 10748239 Free PMC article.

10

Immune responses to the HLA-A*0201-restricted epitopes of tyrosinase and glycoprotein 100 enable control of melanoma outgrowth in HLA-A*0201-transgenic mice.

Mullins DW, Bullock TN, Colella TA, Robila VV, Engelhard VH. Mullins DW, et al. Among authors: engelhard vh. J Immunol. 2001 Nov 1;167(9):4853-60. doi: 10.4049/jimmunol.167.9.4853. J Immunol. 2001. PMID: 11673489

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

204 results

Search Page